INDEMNIFICATION AGREEMENTIndemnification Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • New York
This Indemnification Agreement (this “Agreement”) is entered into as of , by and between China Nuokang Bio-Pharmaceutical Inc., a Cayman Islands company (the “Company”) and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.
EMPLOYMENT AGREEMENTEmployment Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • New York
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of , by and between China Nuokang Bio-Pharmaceutical Inc., a company incorporated and existing under the laws of the Cayman Islands (the “Company”), and [ID/Passport Number: ], an individual (the “Executive”). The term “Company” as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its direct or indirect parent companies, subsidiaries, affiliates, or subsidiaries or affiliates of its parent companies (collectively, the “Group”).
Business Operation AgreementBusiness Operation Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
This Business Operation Agreement (the “Agreement”) is entered into on December 14, 2007 by and among the following parties in Shenyang City, Liaoning Province, the PRC:
Real Estate Lease ContractReal Estate Lease Contract • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
This Contract (the “Contract”) is made and entered into by the parties below in Penglai City, Shandong Province, People’s Republic of China on August 22, 2006:
CHINA NUOKANG BIO-PHARMACEUTICAL PTY PREFERENCE A SHARES PURCHASE AGREEMENT DECEMBER 20, 2007Preference a Shares Purchase Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • California
This Preference A Shares Purchase Agreement (the “Agreement”) is made as of the 20th day of December, 2007 by and among CHINA NUOKANG BIO-PHARMACEUTICAL PTY (formerly Brighter Sky Limited), a Cayman Islands exempted company (the “Company”), the person whose name is set out on Schedule 1 attached hereto (the “Management Shareholder”) and the investors listed on Exhibit A attached hereto (the “Purchasers”).
REPURCHASE AGREEMENTRepurchase Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • New York
This Repurchase Agreement (the “Agreement”), dated as of December 20, 2007, is by and between CHINA NUOKANG BIO-PHARMACEUTICAL PTY, a company incorporated and existing under the laws of the Cayman Islands (the “Purchaser” or “Company”), and Anglo China Bio-technology Investment Holdings Limited, a company incorporated and existing under the laws of the British Virgin Islands (the “Seller”). The Purchaser and the Seller are sometimes referred to collectively herein as the “Parties.”
Hunnan New District State-owned Land Use Right Grant Contract ShenNanTuChuHeZi (2005) No.40State-Owned Land Use Right Grant Contract • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
CHINA NUOKANG BIO-PHARMACEUTICAL PTY RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTRight of First Refusal and Co-Sale Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • California
This Right of First Refusal and Co-Sale Agreement (the “Agreement”) is made and entered into as of December 20, 2007 by and among CHINA NUOKANG BIO-PHARMACEUTICAL PTY (formerly Brighter Sky Limited), a Cayman Islands exempted company (the “Company”), Anglo China Bio-Technology Investment Holdings Limited and Britain Ukan Technology Investment Holdings (Group) Limited, each a company organized and existing under the laws of the British Virgin Islands (collectively, the “Management Holding Companies”), the person set forth on Exhibit A hereto (the “Management Shareholder”) and the holders of Preference A Shares listed on Exhibit A hereto (collectively, the “Preference A Holders” or “Investors”).
Equity Pledge AgreementEquity Pledge Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
This Equity Pledge Agreement (the “Agreement”) is entered into on December 14, 2007 in Shenyang, China by and between the following parties:
EXCLUSIVE CALL OPTION AGREEMENTExclusive Call Option Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
The Exclusive Call Option Agreement (this “Agreement”) is entered into as of December 14, 2007 among the following parties in Shenyang, the People’s Republic of China (the “PRC”):
EXCLUSIVE TECHNOLOGY SUPPORT AND MANAGEMENT CONSULTING SERVICE AGREEMENTExclusive Technology Support and Management Consulting Service Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
This Exclusive Technology Support and Management Consulting Service Agreement (the “Agreement”) is entered into as of December 14, 2007 between the following parties in Shenyang, the People’s Republic of China (the “PRC”):
DATED July 10, 2009 VENOMICS HONG KONG LIMITED and LIAONING NUOKANG MEDICINES CO., LTD. and VENOMICS PTY LIMITED and QRXPHARMA LIMITED SUBSCRIPTION AGREEMENT relating to shares in VENOMICS HONG KONG LIMITEDSubscription Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • Hong Kong
CHINA NUOKANG BIO-PHARMACEUTICAL PTY (incorporated in the Cayman Islands)Side Letter • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
CHINA NUOKANG BIO-PHARMACEUTICAL PTY VOTING AGREEMENTVoting Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • California
This Voting Agreement (the “Agreement”) is made and entered into as of December 20, 2007 by and among CHINA NUOKANG BIO-PHARMACEUTICAL PTY (formerly Brighter Sky Limited), a Cayman Islands exempted company (the “Company”), Anglo China Bio-Technology Investment Holdings Limited and Britain Ukan Technology Investment Holdings (Group) Limited, each a company organized and existing under the laws of the British Virgin Islands (collectively, the “Management Holding Companies”), the person set forth on Exhibit A hereto (the “Management Shareholder”) and the holders of Preference A Shares listed on Exhibit A hereto (collectively, the “Preference A Holders” or “Investors”).
ALPROSTADIL INJECTION (PROSTAGLANDIN E1) EXCLUSIVE REGIONAL DISTRIBUTION AGREEMENTExclusive Regional Distribution Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc.
CHINA NUOKANG BIO-PHARMACEUTICAL PTY INVESTORS’ RIGHTS AGREEMENT December 20, 2007Investors’ Rights Agreement • November 20th, 2009 • China Nuokang Bio-Pharmaceutical Inc. • California
This Investors’ Rights Agreement (this “Agreement”) is made as of the 20th day of December 2007, by and among CHINA NUOKANG BIO-PHARMACEUTICAL PTY (formerly Brighter Sky Limited), a Cayman Islands exempted company (the “Company”), Anglo China Bio-Technology Investment Holdings Limited and Britain Ukan Technology Investment Holdings (Group) Limited, each a company organized and existing under the laws of the British Virgin Islands (collectively, the “Management Holding Companies”), the person set forth on Exhibit A hereto (the “Management Shareholder”) and the holders of Preference A Shares listed on Exhibit A hereto (collectively, the “Preference A Holders” or “Investors”).
